Merck | MRK - Рыночная капитализация

Биржевая цена
109.14
Изменение за день
-1.81 -1.63%
Ежемесячно
-9.27%
Ежегодный
31.08%
Q2 прогноз
109.51




Рыночная капитализация Изменить Дата
AbbVie USD 360.74B 23.94B 2026-04
Abbott USD 168.02B 10.39B 2026-04
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 187.49B 11.24B 2026-04
AstraZeneca USD 214.75B 86.5B 2026-04
Biogen USD 28.34B 1.44B 2026-04
Bristol-Myers Squibb USD 122.54B 1.29B 2026-04
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 882.91B 13.89B 2026-04
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 80.41B 3.39B 2026-04
Glaxosmithkline GBP 99.93B 13.05B 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 279.96B 18.7B 2026-04
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Pacira USD 1.17B 105M 2026-04
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.78B 185M 2026-04
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Zoetis USD 55.45B 9.4B 2025-12